AMNEAL PHARMACEUTICALS, INC.
AMRX US03168L1052
Amneal Pharmaceuticals Inc is a global pharmaceutical company operating primarily in the U.S., India, and Ireland. With three reportable segments; Generics, Specialty, and AvKARE - It develop, manufacture, and distribute a diverse portfolio of essential medicines. The Generics segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
Annual Performance 1
| 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -2% | -59% | 188% | 32% | 1% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
| Person | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Kiely John |
9.23 USD |
32,000 Sold |
295,360 USD |
27/08/2025 | 27/08/2025 |
| Shah Nikita EX VP |
9.50 USD |
6,340 Sold |
60,230 USD |
22/08/2025 | 25/08/2025 |
| Shah Nikita EX VP |
9.66 USD |
114,492 Sold |
1,105,993 USD |
22/08/2025 | 22/08/2025 |
| Boyer Andrew S EX VP |
9.38 USD |
279,244 Sold |
2,619,309 USD |
20/08/2025 | 20/08/2025 |
| Konidaris Tasos PR |
9.43 USD |
219,159 Sold |
2,066,669 USD |
13/08/2025 | 15/08/2025 |
| Shah Nikita EX VP |
9.29 USD |
71,694 Sold |
666,037 USD |
14/08/2025 | 14/08/2025 |
| Konidaris Tasos EX VP |
9.30 USD |
119,206 Sold |
1,108,616 USD |
13/08/2025 | 14/08/2025 |
| Konidaris Tasos EX VP |
9.22 USD |
161,365 Sold |
1,487,785 USD |
13/08/2025 | 13/08/2025 |
| Shah Nikita EX VP |
9.04 USD |
50,000 Sold |
452,000 USD |
12/08/2025 | 12/08/2025 |
| Boyer Andrew S EX VP |
9.05 USD |
33,436 Sold |
302,596 USD |
12/08/2025 | 12/08/2025 |